MariMed (MRMD) CEO Jon Levine exercises RSUs and has shares withheld for taxes
Rhea-AI Filing Summary
MARIMED INC. President and CEO Jon R. Levine reported equity compensation activity involving company common stock and restricted stock units. He exercised 46,875 RSUs into an equal number of common shares, and 16,243 shares were withheld by the company to cover tax obligations related to this vesting.
Following these transactions, Levine directly held 21,338,618 shares of common stock. An additional 6,684,640 shares are held by the Jon Levine Family Trust for the benefit of his spouse and children, for which he disclaims beneficial ownership. After this vesting, 140,625 RSUs from the November 29, 2024 grant remain outstanding, scheduled to vest in three equal installments on November 29, 2026, May 29, 2027 and November 29, 2027.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 30,632 shares
Net Buy
4 txns
Insider
Levine Jon R
Role
President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units (RSU) | 46,875 | $0.00 | $0.00 |
| Exercise | Common stock | 46,875 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common stock | 16,243 | $0.0805 | $1K |
| holding | Common stock | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units (RSU) — 140,625 shares (Direct);
Common stock — 21,338,618 shares (Direct);
Common stock — 6,684,640 shares (Indirect, By the Jon Levine Family Trust)
Footnotes (4)
- F1. RSUs convert to shares of common stock on a one-for-one basis.
- F2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
- F3. These shares are held in trust for the benefit of the Reporting Person's spouse and children. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F4. The RSUs were granted on November 29, 2024; the remaining RSUs under this grant will vest in three equal installments on each of November 29, 2026, May 29, 2027 and November 29, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.
Key Figures
RSUs exercised: 46,875 shares
Shares withheld for taxes: 16,243 shares at $0.0805
Direct common shares after transaction: 21,354,861 shares
+4 more
7 metrics
RSUs exercised
46,875 shares
Restricted Stock Units converted to common stock on May 29, 2026
Shares withheld for taxes
16,243 shares at $0.0805
Withheld to satisfy tax obligations on RSU vesting
Direct common shares after transaction
21,354,861 shares
Direct ownership following May 29, 2026 transactions
Indirect trust holdings
6,684,640 shares
Held by Jon Levine Family Trust; beneficial ownership disclaimed
Remaining RSUs
140,625 RSUs
Outstanding from November 29, 2024 grant after current vesting
Future vesting dates
Nov 29 2026, May 29 2027, Nov 29 2027
Three equal installments for remaining RSUs
RSU conversion ratio
1 RSU : 1 share
RSUs convert to common stock on a one-for-one basis
Key Terms
Restricted Stock Units (RSU), tax withholding obligations, Section 16, vesting, +1 more
5 terms
Restricted Stock Units (RSU) financial
"security_title: "Restricted Stock Units (RSU)""
tax withholding obligations financial
"withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting"
Section 16 regulatory
"beneficial owner of these securities for purposes of Section 16 or for any other purpose"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
vesting financial
"in connection with the vesting of RSUs"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did MariMed (MRMD) CEO Jon Levine report in this Form 4?
Jon Levine reported routine equity compensation activity, exercising 46,875 restricted stock units into common shares. The company withheld 16,243 shares for taxes, updating his direct and indirect holdings and the remaining RSU balance under a prior grant.
What RSU grant details are disclosed for MariMed (MRMD) CEO Jon Levine?
The RSUs were granted on November 29, 2024 and convert to common stock one-for-one. After the reported vesting, 140,625 RSUs remain, vesting in three equal installments on November 29, 2026, May 29, 2027 and November 29, 2027.